메뉴 건너뛰기




Volumn 8, Issue 9, 2013, Pages

Impact of Glutathione-S-Transferases (GST) Polymorphisms and Hypermethylation of Relevant Genes on Risk of Prostate Cancer Biochemical Recurrence: A Meta-Analysis

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE;

EID: 84884526271     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074775     Document Type: Article
Times cited : (17)

References (37)
  • 2
    • 63249118690 scopus 로고    scopus 로고
    • Screening and prostate-cancer mortality in a randomized European study
    • Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, et al. (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360: 1320-1328.
    • (2009) N Engl J Med , vol.360 , pp. 1320-1328
    • Schroder, F.H.1    Hugosson, J.2    Roobol, M.J.3    Tammela, T.L.4    Ciatto, S.5
  • 3
    • 84856200634 scopus 로고    scopus 로고
    • Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up
    • Andriole GL, Crawford ED, Grubb RL, (2012) Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 104: 125-132.
    • (2012) J Natl Cancer Inst , vol.104 , pp. 125-132
    • Andriole, G.L.1    Crawford, E.D.2    Grubb, R.L.3
  • 4
    • 0037304517 scopus 로고    scopus 로고
    • Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer
    • Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, et al. (2003) Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169: 517-523.
    • (2003) J Urol , vol.169 , pp. 517-523
    • Han, M.1    Partin, A.W.2    Zahurak, M.3    Piantadosi, S.4    Epstein, J.I.5
  • 5
    • 84873270023 scopus 로고    scopus 로고
    • Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience
    • Busch J, Stephan C, Herold A, Erber B, Kempkensteffen C, et al. (2012) Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience. BJU Int 110: E985-990.
    • (2012) BJU Int , vol.110
    • Busch, J.1    Stephan, C.2    Herold, A.3    Erber, B.4    Kempkensteffen, C.5
  • 6
    • 41149131215 scopus 로고    scopus 로고
    • A nomogram predicting long-term biochemical recurrence after radical prostatectomy
    • Suardi N, Porter CR, Reuther AM, Walz J, Kodama K, et al. (2008) A nomogram predicting long-term biochemical recurrence after radical prostatectomy. Cancer 112: 1254-1263.
    • (2008) Cancer , vol.112 , pp. 1254-1263
    • Suardi, N.1    Porter, C.R.2    Reuther, A.M.3    Walz, J.4    Kodama, K.5
  • 7
    • 0037319283 scopus 로고    scopus 로고
    • Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen
    • Freedland SJ, Sutter ME, Dorey F, Aronson WJ, (2003) Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen. Urology 61: 365-369.
    • (2003) Urology , vol.61 , pp. 365-369
    • Freedland, S.J.1    Sutter, M.E.2    Dorey, F.3    Aronson, W.J.4
  • 8
    • 22844434877 scopus 로고    scopus 로고
    • Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
    • Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, et al. (2005) Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294: 433-439.
    • (2005) JAMA , vol.294 , pp. 433-439
    • Freedland, S.J.1    Humphreys, E.B.2    Mangold, L.A.3    Eisenberger, M.4    Dorey, F.J.5
  • 9
    • 0033526309 scopus 로고    scopus 로고
    • Natural history of progression after PSA elevation following radical prostatectomy
    • Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, et al. (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281: 1591-1597.
    • (1999) JAMA , vol.281 , pp. 1591-1597
    • Pound, C.R.1    Partin, A.W.2    Eisenberger, M.A.3    Chan, D.W.4    Pearson, J.D.5
  • 10
    • 33646945083 scopus 로고    scopus 로고
    • Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
    • Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, et al. (2006) Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 98: 715-717.
    • (2006) J Natl Cancer Inst , vol.98 , pp. 715-717
    • Stephenson, A.J.1    Scardino, P.T.2    Eastham, J.A.3    Bianco Jr., F.J.4    Dotan, Z.A.5
  • 13
    • 84867394102 scopus 로고    scopus 로고
    • Association of GSTM1 null allele with prostate cancer risk: evidence from 36 case-control studies
    • Wei B, Xu Z, Zhou Y, Ruan J, Cheng H, et al. (2012) Association of GSTM1 null allele with prostate cancer risk: evidence from 36 case-control studies. PLoS One 7: e46982.
    • (2012) PLoS One , vol.7
    • Wei, B.1    Xu, Z.2    Zhou, Y.3    Ruan, J.4    Cheng, H.5
  • 16
    • 71349088365 scopus 로고    scopus 로고
    • Polymorphisms in glutathione S-transferase genes increase risk of prostate cancer biochemical recurrence differentially by ethnicity and disease severity
    • Nock NL, Bock C, Neslund-Dudas C, Beebe-Dimmer J, Rundle A, et al. (2009) Polymorphisms in glutathione S-transferase genes increase risk of prostate cancer biochemical recurrence differentially by ethnicity and disease severity. Cancer Causes Control 20: 1915-1926.
    • (2009) Cancer Causes Control , vol.20 , pp. 1915-1926
    • Nock, N.L.1    Bock, C.2    Neslund-Dudas, C.3    Beebe-Dimmer, J.4    Rundle, A.5
  • 17
    • 33749055943 scopus 로고    scopus 로고
    • Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis
    • Agalliu I, Lin DW, Salinas CA, Feng Z, Stanford JL, (2006) Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. Prostate 66: 1535-1541.
    • (2006) Prostate , vol.66 , pp. 1535-1541
    • Agalliu, I.1    Lin, D.W.2    Salinas, C.A.3    Feng, Z.4    Stanford, J.L.5
  • 18
    • 84867303446 scopus 로고    scopus 로고
    • Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence
    • Dluzniewski PJ, Wang MH, Zheng SL, De Marzo AM, Drake CG, et al. (2012) Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence. Cancer Epidemiol Biomarkers Prev 21: 1774-1782.
    • (2012) Cancer Epidemiol Biomarkers Prev , vol.21 , pp. 1774-1782
    • Dluzniewski, P.J.1    Wang, M.H.2    Zheng, S.L.3    De Marzo, A.M.4    Drake, C.G.5
  • 19
    • 77951748989 scopus 로고    scopus 로고
    • Methylated genes as potential biomarkers in prostate cancer
    • Phe V, Cussenot O, Roupret M, (2010) Methylated genes as potential biomarkers in prostate cancer. BJU Int 105: 1364-1370.
    • (2010) BJU Int , vol.105 , pp. 1364-1370
    • Phe, V.1    Cussenot, O.2    Roupret, M.3
  • 20
    • 84888204951 scopus 로고    scopus 로고
    • Epigenetic biomarkers in prostate cancer: Current and future uses
    • Chiam K, Ricciardelli C, Bianco-Miotto T (2012) Epigenetic biomarkers in prostate cancer: Current and future uses. Cancer Lett.
    • (2012) Cancer Lett
    • Chiam, K.1    Ricciardelli, C.2    Bianco-Miotto, T.3
  • 21
    • 84861153520 scopus 로고    scopus 로고
    • Global methylation profiling for risk prediction of prostate cancer
    • Mahapatra S, Klee EW, Young CY, Sun Z, Jimenez RE, et al. (2012) Global methylation profiling for risk prediction of prostate cancer. Clin Cancer Res 18: 2882-2895.
    • (2012) Clin Cancer Res , vol.18 , pp. 2882-2895
    • Mahapatra, S.1    Klee, E.W.2    Young, C.Y.3    Sun, Z.4    Jimenez, R.E.5
  • 22
    • 79959885041 scopus 로고    scopus 로고
    • Association of tissue promoter methylation levels of APC, TGFbeta2, HOXD3 and RASSF1A with prostate cancer progression
    • Liu L, Kron KJ, Pethe VV, Demetrashvili N, Nesbitt ME, et al. (2011) Association of tissue promoter methylation levels of APC, TGFbeta2, HOXD3 and RASSF1A with prostate cancer progression. Int J Cancer 129: 2454-2462.
    • (2011) Int J Cancer , vol.129 , pp. 2454-2462
    • Liu, L.1    Kron, K.J.2    Pethe, V.V.3    Demetrashvili, N.4    Nesbitt, M.E.5
  • 23
    • 37449024720 scopus 로고    scopus 로고
    • CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer
    • Ellinger J, Haan K, Heukamp LC, Kahl P, Buttner R, et al. (2008) CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer. Prostate 68: 42-49.
    • (2008) Prostate , vol.68 , pp. 42-49
    • Ellinger, J.1    Haan, K.2    Heukamp, L.C.3    Kahl, P.4    Buttner, R.5
  • 24
    • 38649101553 scopus 로고    scopus 로고
    • CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer
    • Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, et al. (2008) CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer. Urology 71: 161-167.
    • (2008) Urology , vol.71 , pp. 161-167
    • Ellinger, J.1    Bastian, P.J.2    Jurgan, T.3    Biermann, K.4    Kahl, P.5
  • 25
    • 20344366824 scopus 로고    scopus 로고
    • Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy
    • Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, et al. (2005) Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy. Clin Cancer Res 11: 4037-4043.
    • (2005) Clin Cancer Res , vol.11 , pp. 4037-4043
    • Bastian, P.J.1    Palapattu, G.S.2    Lin, X.3    Yegnasubramanian, S.4    Mangold, L.A.5
  • 26
    • 38449120703 scopus 로고    scopus 로고
    • CD44 and PTGS2 methylation are independent prognostic markers for biochemical recurrence among prostate cancer patients with clinically localized disease
    • Woodson K, O'Reilly KJ, Ward DE, Walter J, Hanson J, et al. (2006) CD44 and PTGS2 methylation are independent prognostic markers for biochemical recurrence among prostate cancer patients with clinically localized disease. Epigenetics 1: 183-186.
    • (2006) Epigenetics , vol.1 , pp. 183-186
    • Woodson, K.1    O'Reilly, K.J.2    Ward, D.E.3    Walter, J.4    Hanson, J.5
  • 27
    • 28544442448 scopus 로고    scopus 로고
    • Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy
    • Rosenbaum E, Hoque MO, Cohen Y, Zahurak M, Eisenberger MA, et al. (2005) Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy. Clinical Cancer Research 11: 8321-8325.
    • (2005) Clinical Cancer Research , vol.11 , pp. 8321-8325
    • Rosenbaum, E.1    Hoque, M.O.2    Cohen, Y.3    Zahurak, M.4    Eisenberger, M.A.5
  • 28
    • 77951748989 scopus 로고    scopus 로고
    • Methylated genes as potential biomarkers in prostate cancer
    • Phe V, Cussenot O, Roupret M, (2010) Methylated genes as potential biomarkers in prostate cancer. BJU International 105: 1364-1370.
    • (2010) BJU International , vol.105 , pp. 1364-1370
    • Phe, V.1    Cussenot, O.2    Roupret, M.3
  • 29
    • 33846221516 scopus 로고    scopus 로고
    • Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy
    • Discussion 674
    • Bastian PJ, Ellinger J, Heukamp LC, Kahl P, Muller SC, et al. (2007) Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy. Eur Urol 51: 665-674; discussion 674.
    • (2007) Eur Urol , vol.51 , pp. 665-674
    • Bastian, P.J.1    Ellinger, J.2    Heukamp, L.C.3    Kahl, P.4    Muller, S.C.5
  • 33
    • 84959801619 scopus 로고
    • Statistical aspects of the analysis of data from retrospective studies of disease
    • Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
    • (1959) J Natl Cancer Inst , vol.22 , pp. 719-748
    • Mantel, N.1    Haenszel, W.2
  • 34
    • 0030922816 scopus 로고    scopus 로고
    • Bias in meta-analysis detected by a simple, graphical test
    • Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
    • (1997) BMJ , vol.315 , pp. 629-634
    • Egger, M.1    Davey Smith, G.2    Schneider, M.3    Minder, C.4
  • 35
    • 0035918543 scopus 로고    scopus 로고
    • Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk
    • Gsur A, Haidinger G, Hinteregger S, Bernhofer G, Schatzl G, et al. (2001) Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int J Cancer 95: 152-155.
    • (2001) Int J Cancer , vol.95 , pp. 152-155
    • Gsur, A.1    Haidinger, G.2    Hinteregger, S.3    Bernhofer, G.4    Schatzl, G.5
  • 36
    • 84859297213 scopus 로고    scopus 로고
    • Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies
    • Trock BJ, Brotzman MJ, Mangold LA, Bigley JW, Epstein JI, et al. (2012) Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies. BJU Int 110: 56-62.
    • (2012) BJU Int , vol.110 , pp. 56-62
    • Trock, B.J.1    Brotzman, M.J.2    Mangold, L.A.3    Bigley, J.W.4    Epstein, J.I.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.